Intranasal administration of ceramide liposome suppresses allergic rhinitis by targeting CD300f in murine models.
Ide T, Izawa K, Diono W, Kamei A, Ando T, Kaitani A, Maehara A, Yoshikawa A, Yamamoto R, Uchida S, Wang H, Kojima M, Maeda K, Nakano N, Nakamura M, Shimizu T, Ogawa H, Okumura K, Matsumoto F, Ikeda K, Goto M, Kitaura J.
Ide T, et al.
Sci Rep. 2024 Apr 10;14(1):8398. doi: 10.1038/s41598-024-58923-w.
Sci Rep. 2024.
PMID: 38600251
Free PMC article.